Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Ivo H, De Leeuw"'
Publikováno v:
Current Diabetes Reviews. 2:113-130
This review addresses the current concepts in our understanding of the epidemiology, mechanisms, symptoms, clinical consequences, diagnosis and treatment of delayed gastric emptying in patients with diabetes. Upper gastrointestinal symptoms, particul
Autor:
Carolien van Gils, P. Abrams, Begoña Manuel-y-Keenoy, Ivo H. De Leeuw, Luc Van Gaal, Ann Van Campenhout, J. Vertommen, Petra Aerts
Publikováno v:
Journal of the American College of Nutrition
The aim of this study was to compare oxidative stress status (OSS) with blood glucose and lipid changes during the fasting, postprandial and postabsorptive phases in type 1 diabetes mellitus.Twenty-three patients on intensive insulin treatment receiv
Publikováno v:
Annals of the New York Academy of Sciences
Blood glucose, lipids, alpha-tocopherol, and malondialdehyde were monitored in type 1 diabetes mellitus patients for 8 hours after a standard fat-rich breakfast and lunch. Although glucose and triglycerides increased, alpha-tocopherol decreased and m
Autor:
Kristof Thielemans, Luc Van Gaal, Christophe De Block, Eric Van Marck, Johannes Bogers, Willy Coopmans, Gert Colpin, Paul A. Pelckmans, Viviane Van Hoof, Manou Martin, Roger Bouillon, Ivo H. De Leeuw
Publikováno v:
Diabetes care
OBJECTIVE—Parietal cell antibodies (PCAs) are found in 20% of type 1 diabetic patients, denoting autoimmune gastritis and pernicious anemia, which may predispose to enterochromaffin-like (ECL) cell hyper/dysplasia and gastric carcinoid tumors. We e
Autor:
P. Abrams, Begoña Manuel-y-Keenoy, Dimitri Messeri, Luc Van Gaal, J. Vertommen, Alessandro Poscia, Ivo H. De Leeuw
Publikováno v:
Diabetes/metabolism research and reviews
Pre-prandial glucose gives insufficient information on glycemic excursions throughout the day. We aimed to test a continuous subcutaneous glucose-monitoring device (GlucoDay) to describe postprandial glucose changes.In 23 T1DM patients, 24-h GlucoDay
Autor:
Margareta Ieven, Kristien Van Acker, Ivo H. De Leeuw, Luc Van Gaal, Johannes Bogers, Eric Van Marck, Paul A. Pelckmans, Christophe De Block
Publikováno v:
Diabetes Care. 26:82-88
OBJECTIVE—Approximately 15–20% of type 1 diabetic patients exhibit parietal cell antibodies (PCAs) targeting gastric H+/K+ATPase. We examined whether iron deficiency anemia, pernicious anemia, and autoimmune gastritis, which may predispose to gas
Autor:
Daubresse Jc, Chantal Mathieu, Ilse Weets, Bart Keymeulen, Raoul Rooman, Frans Gorus, Marc V. L. Du Caju, Daniel Pipeleers, Danielle Rocour-Brumioul, Raoul Rottiers, Ivo H. De Leeuw
Publikováno v:
Diabetes Care. 25:840-846
OBJECTIVE—A worldwide increase in the incidence of childhood type 1 diabetes has been observed. Because in various countries the majority of new type 1 diabetic patients are diagnosed in adulthood, we investigated whether the rising incidence of th
Publikováno v:
Diabetes research and clinical practice
The prandial glucose regulator repaglinide has a rapid onset of action, a short half-life and is metabolised mainly by the liver. Here we report the findings of a 10-week, double-blind, parallel, placebo controlled, randomised trial with repaglinide
Publikováno v:
The American Journal of Clinical Nutrition. 72:1142-1149
BACKGROUND Vitamin E supplementation has been proposed as adjunctive therapy to counteract the increased LDL oxidation in diabetes and thus prevent or delay cardiovascular complications. OBJECTIVE The objective of this study was to investigate the ef
Autor:
Paul A. Pelckmans, Eric Van Marck, Luc Van Gaal, Johannes Bogers, Christophe De Block, Peter Michielsen, Ivo H. De Leeuw
Publikováno v:
Journal of Diabetes and its Complications. 14:116-120
The history of a 45-year-old male type 1 diabetic patient is presented. At the age of 29 years, he was diagnosed to have an autoimmune hepatitis with incipient liver cirrhosis. Five years later, a successful liver/pancreas transplantation was perform